TY - JOUR
T1 - Outcomes Associated With Early RBC Transfusion in Pediatric Severe Sepsis
T2 - A Propensity-Adjusted Multicenter Cohort Study
AU - Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN)
AU - Muszynski, Jennifer A.
AU - Banks, Russell
AU - Reeder, Ron W.
AU - Hall, Mark W.
AU - Berg, Robert A.
AU - Zuppa, Athena
AU - Shanley, Thomas P.
AU - Cornell, Timothy T.
AU - Newth, Christopher J.L.
AU - Pollack, Murray M.
AU - Wessel, David
AU - Doctor, Allan
AU - Lin, John C.
AU - Harrison, Rick E.
AU - Meert, Kathleen L.
AU - Dean, J. Michael
AU - Holubkov, Richard
AU - Carcillo, Joseph A.
N1 - Publisher Copyright:
Copyright © 2021 by the Shock Society.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - BACKGROUND: Little is known about the epidemiology of and outcomes related to red blood cell (RBC) transfusion in septic children across multiple centers. We performed propensity-adjusted secondary analyses of the Biomarker Phenotyping of Pediatric Sepsis and Multiple Organ Failure (PHENOMS) study to test the hypothesis that early RBC transfusion is associated with fewer organ failure-free days in pediatric severe sepsis. METHODS: Four hundred one children were enrolled in the parent study. Children were excluded from these analyses if they received extracorporeal membrane oxygenation (n = 22) or died (n = 1) before sepsis day 2. Propensity-adjusted analyses compared children who received RBC transfusion on or before sepsis day 2 (early RBC transfusion) with those who did not. Logistic regression was used to model the propensity to receive early RBC transfusion. A weighted cohort was constructed using stabilized inverse probability of treatment weights. Variables in the weighted cohort with absolute standardized differences >0.15 were added to final multivariable models. RESULTS: Fifty percent of children received at least one RBC transfusion. The majority (68%) of first transfusions were on or before sepsis day 2. Early RBC transfusion was not independently associated with organ failure-free (-0.34 [95%CI: -2, 1.3] days) or PICU-free days (-0.63 [-2.3, 1.1]), but was associated with the secondary outcome of higher mortality (aOR 2.9 [1.1, 7.9]). CONCLUSIONS: RBC transfusion is common in pediatric severe sepsis and may be associated with adverse outcomes. Future studies are needed to clarify these associations, to understand patient-specific transfusion risks, and to develop more precise transfusion strategies.
AB - BACKGROUND: Little is known about the epidemiology of and outcomes related to red blood cell (RBC) transfusion in septic children across multiple centers. We performed propensity-adjusted secondary analyses of the Biomarker Phenotyping of Pediatric Sepsis and Multiple Organ Failure (PHENOMS) study to test the hypothesis that early RBC transfusion is associated with fewer organ failure-free days in pediatric severe sepsis. METHODS: Four hundred one children were enrolled in the parent study. Children were excluded from these analyses if they received extracorporeal membrane oxygenation (n = 22) or died (n = 1) before sepsis day 2. Propensity-adjusted analyses compared children who received RBC transfusion on or before sepsis day 2 (early RBC transfusion) with those who did not. Logistic regression was used to model the propensity to receive early RBC transfusion. A weighted cohort was constructed using stabilized inverse probability of treatment weights. Variables in the weighted cohort with absolute standardized differences >0.15 were added to final multivariable models. RESULTS: Fifty percent of children received at least one RBC transfusion. The majority (68%) of first transfusions were on or before sepsis day 2. Early RBC transfusion was not independently associated with organ failure-free (-0.34 [95%CI: -2, 1.3] days) or PICU-free days (-0.63 [-2.3, 1.1]), but was associated with the secondary outcome of higher mortality (aOR 2.9 [1.1, 7.9]). CONCLUSIONS: RBC transfusion is common in pediatric severe sepsis and may be associated with adverse outcomes. Future studies are needed to clarify these associations, to understand patient-specific transfusion risks, and to develop more precise transfusion strategies.
UR - http://www.scopus.com/inward/record.url?scp=85122771592&partnerID=8YFLogxK
U2 - 10.1097/SHK.0000000000001863
DO - 10.1097/SHK.0000000000001863
M3 - Article
C2 - 34628452
AN - SCOPUS:85122771592
SN - 1540-0514
VL - 57
SP - 88
EP - 94
JO - Shock (Augusta, Ga.)
JF - Shock (Augusta, Ga.)
IS - 1
ER -